Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study.

Deaño RC, Glassner-Kolmin C, Rubenfire M, Frost A, Visovatti S, McLaughlin VV, Gomberg-Maitland M.

JAMA Intern Med. 2013 May 27;173(10):887-93. doi: 10.1001/jamainternmed.2013.319.

PMID:
23568223
2.
3.

[Is pulmonary hypertension diagnosed correctly and early enough? Highly relevant dilemma: incomplete diagnostic, inaccurate treatment].

Rosenkranz S.

Dtsch Med Wochenschr. 2013 Sep;138(37):1820. doi: 10.1055/s-0032-1329060. Epub 2013 Sep 4. German. No abstract available.

PMID:
24006160
4.

Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry.

Farber HW, Miller DP, Meltzer LA, McGoon MD.

J Heart Lung Transplant. 2013 Nov;32(11):1114-22. doi: 10.1016/j.healun.2013.08.010. Epub 2013 Sep 10.

PMID:
24035189
5.

Incremental burden of disease in patients diagnosed with pulmonary arterial hypertension receiving monotherapy and combination vasodilator therapy.

Small M, Piercy J, Pike J, Cerulli A.

Adv Ther. 2014 Feb;31(2):168-79. doi: 10.1007/s12325-014-0094-z. Epub 2014 Jan 22.

PMID:
24449285
6.

[Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].

Kaemmerer H, Gorenflo M, Hoeper M, Huscher D, Ewert P, Pittrow D.

Dtsch Med Wochenschr. 2013 Jun;138(23):1247-52. doi: 10.1055/s-0033-1343189. Epub 2013 May 29. Review. German.

PMID:
23720182
8.

Combination therapy in pulmonary arterial hypertension.

Pugh ME, Hemnes AR, Robbins IM.

Clin Chest Med. 2013 Dec;34(4):841-55. doi: 10.1016/j.ccm.2013.08.007. Epub 2013 Oct 17. Review.

PMID:
24267308
9.

Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral.

Badagliacca R, Pezzuto B, Poscia R, Mancone M, Papa S, Marcon S, Valli G, Sardella G, Ferrante F, Iacoboni C, Parola D, Fedele F, Vizza CD.

J Heart Lung Transplant. 2012 Apr;31(4):364-72. doi: 10.1016/j.healun.2011.12.011. Epub 2012 Jan 29.

PMID:
22289484
10.
11.

The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension.

Nickel N, Golpon H, Greer M, Knudsen L, Olsson K, Westerkamp V, Welte T, Hoeper MM.

Eur Respir J. 2012 Mar;39(3):589-96. doi: 10.1183/09031936.00092311. Epub 2011 Sep 1.

12.

Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies.

Keir GJ, Walsh SL, Gatzoulis MA, Marino PS, Dimopoulos K, Alonso R, Raposeiras-Roubin S, Renzoni EA, Maher TM, Wells AU, Wort SJ.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Jul 8;31(2):82-90.

PMID:
25078636
13.

Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension.

de Jesus Perez VA, Rosenzweig E, Rubin LJ, Poch D, Bajwa A, Park M, Jain M, Bourge RC, Kudelko K, Spiekerkoetter E, Liu J, Hsi A, Zamanian RT.

Am J Cardiol. 2012 Nov 15;110(10):1546-50. doi: 10.1016/j.amjcard.2012.07.012. Epub 2012 Jul 30.

PMID:
22853986
14.

A pulmonary hypertension gas exchange severity (PH-GXS) score to assist with the assessment and monitoring of pulmonary arterial hypertension.

Woods PR, Taylor BJ, Frantz RP, Johnson BD.

Am J Cardiol. 2012 Apr 1;109(7):1066-72. doi: 10.1016/j.amjcard.2011.11.042. Epub 2012 Jan 14.

15.

Management of pulmonary arterial hypertension.

Judge EP, Gaine SP.

Curr Opin Crit Care. 2013 Feb;19(1):44-50. doi: 10.1097/MCC.0b013e32835c5137. Review.

PMID:
23242212
16.

Endothelin receptor antagonists for pulmonary arterial hypertension.

Liu C, Chen J.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004434. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD004434.

PMID:
16856046
17.

Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature.

Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M.

Medicine (Baltimore). 2007 Sep;86(5):299-315. Review.

18.

[Two years of multidisciplinary diagnostic and therapeutic experience in patients with pulmonary arterial hypertension].

Tokgözoğlu L, Akdoğan A, Okutucu S, Kaya EB, Aytemir K, Ozkutlu H.

Turk Kardiyol Dern Ars. 2009 Sep;37(6):378-83. Turkish.

19.

Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.

Le Pavec J, Girgis RE, Lechtzin N, Mathai SC, Launay D, Hummers LK, Zaiman A, Sitbon O, Simonneau G, Humbert M, Hassoun PM.

Arthritis Rheum. 2011 Aug;63(8):2456-64. doi: 10.1002/art.30423.

20.

Alternatives to lung transplantation: treatment of pulmonary arterial hypertension.

Corris PA.

Clin Chest Med. 2011 Jun;32(2):399-410. doi: 10.1016/j.ccm.2011.02.015. Review.

PMID:
21511098

Supplemental Content

Support Center